Keyphrases
Parkinson's Disease
100%
Dementia with Lewy Bodies
100%
Cognitive Impairment
100%
Acetylcholinesterase Inhibitors (AChEI)
100%
Parkinson's Disease Dementia
100%
Odds Ratio
46%
Dementia
30%
Cognitive Function
23%
Rating Scales
23%
Behavioral Disturbances
23%
Standardized Mean Difference
23%
Activities of Daily Living
23%
Patients with Parkinson's Disease
15%
Lewy Body Disease
15%
Treatment Group
15%
Tolerability
15%
Adverse Events
15%
Unified Parkinson's Disease Rating Scale (UPDRS)
15%
Du Bois
15%
EmrE
15%
Global Assessment
15%
Statistical Analysis
7%
Neurotransmitters
7%
Alzheimer's Disease
7%
MEDLINE
7%
Search Methods
7%
Dementia with
7%
Patients with Dementia
7%
Continuous Data
7%
Positive Impact
7%
Placebo
7%
CINAHL
7%
Embase
7%
Clinical Features
7%
Search Terms
7%
Cochrane Review
7%
Evidence Support
7%
Therapeutic Benefits
7%
Acetylcholine
7%
PsycINFO
7%
Mini-Mental State Examination
7%
Inclusion Criteria
7%
Parkinsonism
7%
Placebo Groups
7%
Randomized Placebo-controlled Trial
7%
Healthcare Database
7%
Selection Criteria
7%
Perturbation Analysis
7%
Cognitive Improvement
7%
Cochrane
7%
Parkinsonian Symptoms
7%
Tremor
7%
Behavioral Activity
7%
Change Score
7%
Rivastigmine
7%
Ongoing Trials
7%
Inhibitor Treatment
7%
Parkinson
7%
Patients with Cognitive Impairments
7%
Donepezil
7%
Treatment Efficacy
7%
Data Combination
7%
Safety Self-efficacy
7%
Patient Global Impression of Change
7%
Review Manager
7%
Parallel Group Design
7%
Body Remains
7%
Cooperative Study
7%
Review Authors
7%
Clinical Improvement
7%
Motor Score
7%
Lewy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cognitive Defect
100%
Parkinson's Disease
100%
Diffuse Lewy Body Disease
100%
Cholinesterase Inhibitor
100%
Placebo
16%
Behavior Disorder
16%
Adverse Event
11%
Tolerability
11%
Treatment Group
11%
Alzheimer's Disease
5%
Acetylcholine
5%
Clinical Feature
5%
Parkinsonism
5%
Clinical Study
5%
Neurotransmitter
5%
Rivastigmine
5%
Donepezil
5%
Neuroscience
Parkinson's Disease
100%
Dementia with Lewy Bodies
100%
Cognitive Disorders
100%
Acetylcholinesterase Inhibitor
100%
Cognitive Function
17%
Placebo
17%
Behavior Disorder
17%
Neurotransmitter
5%
Alzheimer's Disease
5%
Acetylcholine
5%
Parkinsonism
5%
Tremor
5%
Rivastigmine
5%
Donepezil
5%
Diagnosis of Parkinson's Disease
5%